A detailed history of Huntington National Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Huntington National Bank holds 363 shares of IONS stock, worth $17,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363
Previous 289 25.61%
Holding current value
$17,300
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$42.03 - $53.55 $3,110 - $3,962
74 Added 25.61%
363 $15,000
Q4 2023

Feb 07, 2024

BUY
$43.39 - $51.63 $3,905 - $4,646
90 Added 45.23%
289 $14,000
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $3,542 - $4,419
102 Added 105.15%
199 $8,000
Q1 2023

May 10, 2023

BUY
$33.58 - $41.2 $3,223 - $3,955
96 Added 9600.0%
97 $3,000
Q4 2021

Jan 21, 2022

SELL
$25.61 - $35.1 $332 - $456
-13 Reduced 92.86%
1 $0
Q3 2021

Oct 28, 2021

BUY
$33.54 - $40.55 $436 - $527
13 Added 1300.0%
14 $0
Q2 2021

Jul 30, 2021

SELL
$34.54 - $47.25 $2,141 - $2,929
-62 Reduced 98.41%
1 $0
Q4 2020

Jan 11, 2021

BUY
$45.3 - $60.27 $2,808 - $3,736
62 Added 6200.0%
63 $4,000
Q1 2020

Apr 27, 2020

SELL
$41.6 - $63.4 $14,560 - $22,190
-350 Reduced 99.72%
1 $0
Q4 2019

Jan 17, 2020

BUY
$53.85 - $65.27 $5,654 - $6,853
105 Added 42.68%
351 $21,000
Q2 2019

Jul 23, 2019

BUY
$62.09 - $86.14 $62 - $86
1 Added 0.41%
246 $16,000
Q1 2019

Apr 09, 2019

SELL
$52.92 - $81.17 $20,797 - $31,899
-393 Reduced 61.6%
245 $20,000
Q4 2018

Jan 28, 2019

BUY
$43.37 - $59.54 $17,001 - $23,339
392 Added 159.35%
638 $34,000
Q3 2018

Oct 18, 2018

SELL
$42.88 - $53.7 $22,297 - $27,924
-520 Reduced 67.89%
246 $13,000
Q2 2018

Jul 19, 2018

SELL
$40.53 - $50.7 $22,656 - $28,341
-559 Reduced 42.19%
766 $32,000
Q1 2018

Apr 30, 2018

BUY
$44.08 - $55.05 $4,187 - $5,229
95 Added 7.72%
1,325 $58,000
Q3 2017

Oct 24, 2017

BUY
$45.56 - $59.57 $56,038 - $73,271
1,230
1,230 $62,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.76B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.